VAERS Explorer
Back to explore

Report #2887139

Received Feb 27, 2026

Died
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
PR
Recovered
Not recovered
Vaccinated
Nov 20, 2024
Onset
Dec 5, 2024
Days to onset
15
Hospital days

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH1LM7786
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS299YAJLA

Symptoms (1)

Myocardial infarction

Symptom narrative

heart attack/myocardial infarction; This serious case was reported by a pharmacist via other manufacturer and described the occurrence of myocardial infarction in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 99YAJ) for prophylaxis. Co-suspect products included Tozinameran (Comirnaty) (batch number LM7786) for prophylaxis. The patient's past medical history included allergy (drug reaction). Concurrent medical conditions included hypertension and blood cholesterol increased. Additional patient notes included did not receive any other vaccines within 4 weeks prior to vaccines. On 20-NOV-2024, the patient received the 2nd dose of Shingrix (left arm) and the 1st dose of Comirnaty (unknown deltoid). On 05-DEC-2024, 15 days after receiving Shingrix and Comirnaty, the patient experienced myocardial infarction (Verbatim: heart attack/myocardial infarction) (serious criteria death and GSK medically significant). The patient died on 05-DEC-2024. The reported cause of death was heart attack. An autopsy was not performed. It was unknown if the reporter considered the myocardial infarction to be related to Shingrix. The company considered the myocardial infarction to be unrelated to Shingrix. Additional Information: GSK receipt date: 24-FEB-2026 It was unknown if the patient taking any other medications within 2 weeks of the event starting.; Sender's Comments: A case of Myocardial infarction, 15 days after receiving Shingrix in a 66-year-old male patient. Report is inconsistent with causal relation to the vaccine product, considering absence of biological plausibility and alternative risk factor (H/o hypertension and blood cholesterol increased).; Reported Cause(s) of Death: Heart attack

Current illness

Blood cholesterol increased; Hypertension

Medical history

Medical History/Concurrent Conditions: Allergy (drug reaction); Comments: did not receive any other vaccines within 4 weeks prior to vaccines